(12-291) Assessing Appropriate Usage of Digoxin Immune Fab in the Reversal of Digoxin Induced Toxicity

Wednesday, December 7, 2022

2:00 PM – 3:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Toxicology

Co-Author(s): Terri Gritzer

Primary Author(s)

Blake D. Remensnyder, PharmD
Pharmacy Resident
Conemaugh Memorial Medical Center, Pennsylvania